Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014924075> ?p ?o ?g. }
- W2014924075 endingPage "3001" @default.
- W2014924075 startingPage "2988" @default.
- W2014924075 abstract "Blocking the 2-C-methyl-d-erythrithol-4-phosphate (MEP) pathway for isoprenoid biosynthesis offers interesting prospects for inhibiting Plasmodium or Mycobacterium spp. growth. Fosmidomycin (1) and its homologue FR900098 (2) potently inhibit 1-deoxy-d-xylulose-5-phosphate reductoisomerase (Dxr), a key enzyme in this pathway. Here we introduced aryl or aralkyl substituents at the β-position of the hydroxamate analogue of 2. While direct addition of a β-aryl moiety resulted in poor inhibition, longer linkers between the carbon backbone and the phenyl ring were generally associated with better binding to the enzymes. X-ray structures of the parasite Dxr–inhibitor complexes show that the “longer” compounds generate a substantially different flap structure, in which a key tryptophan residue is displaced, and the aromatic group of the ligand lies between the tryptophan and the hydroxamate’s methyl group. Although the most promising new Dxr inhibitors lack activity against Escherichia coli and Mycobacterium smegmatis, they proved to be highly potent inhibitors of Plasmodium falciparum in vitro growth." @default.
- W2014924075 created "2016-06-24" @default.
- W2014924075 creator A5000801639 @default.
- W2014924075 creator A5003120669 @default.
- W2014924075 creator A5004559759 @default.
- W2014924075 creator A5013501595 @default.
- W2014924075 creator A5019503455 @default.
- W2014924075 creator A5025514242 @default.
- W2014924075 creator A5027829632 @default.
- W2014924075 creator A5037772659 @default.
- W2014924075 creator A5040004308 @default.
- W2014924075 creator A5044518844 @default.
- W2014924075 creator A5051132348 @default.
- W2014924075 creator A5055857585 @default.
- W2014924075 creator A5057216030 @default.
- W2014924075 creator A5066622264 @default.
- W2014924075 creator A5073996940 @default.
- W2014924075 creator A5077135755 @default.
- W2014924075 creator A5087422125 @default.
- W2014924075 date "2015-03-31" @default.
- W2014924075 modified "2023-10-18" @default.
- W2014924075 title "Synthesis and Bioactivity of β-Substituted Fosmidomycin Analogues Targeting 1-Deoxy-<scp>d</scp>-xylulose-5-phosphate Reductoisomerase" @default.
- W2014924075 cites W1523208334 @default.
- W2014924075 cites W1969325303 @default.
- W2014924075 cites W1970058276 @default.
- W2014924075 cites W1972401663 @default.
- W2014924075 cites W1973148945 @default.
- W2014924075 cites W1976826704 @default.
- W2014924075 cites W1993404146 @default.
- W2014924075 cites W1998555588 @default.
- W2014924075 cites W1999458818 @default.
- W2014924075 cites W2008147136 @default.
- W2014924075 cites W2008872195 @default.
- W2014924075 cites W2013467337 @default.
- W2014924075 cites W2020158651 @default.
- W2014924075 cites W2021137848 @default.
- W2014924075 cites W2023372492 @default.
- W2014924075 cites W2025785709 @default.
- W2014924075 cites W2031612794 @default.
- W2014924075 cites W2042353065 @default.
- W2014924075 cites W2046259819 @default.
- W2014924075 cites W2047745904 @default.
- W2014924075 cites W2048365530 @default.
- W2014924075 cites W2050172943 @default.
- W2014924075 cites W2064748510 @default.
- W2014924075 cites W2065348550 @default.
- W2014924075 cites W2067428749 @default.
- W2014924075 cites W2070413611 @default.
- W2014924075 cites W2073322918 @default.
- W2014924075 cites W2078133371 @default.
- W2014924075 cites W2080616046 @default.
- W2014924075 cites W2081056818 @default.
- W2014924075 cites W2081290361 @default.
- W2014924075 cites W2090184692 @default.
- W2014924075 cites W2091643808 @default.
- W2014924075 cites W2102637191 @default.
- W2014924075 cites W2128951621 @default.
- W2014924075 cites W2131441798 @default.
- W2014924075 cites W2133350645 @default.
- W2014924075 cites W2136402448 @default.
- W2014924075 cites W2137461030 @default.
- W2014924075 cites W2141524476 @default.
- W2014924075 cites W2142251083 @default.
- W2014924075 cites W2143243315 @default.
- W2014924075 cites W2164267446 @default.
- W2014924075 cites W2166050191 @default.
- W2014924075 cites W2167489620 @default.
- W2014924075 cites W2172056358 @default.
- W2014924075 cites W2318898459 @default.
- W2014924075 cites W2328958113 @default.
- W2014924075 cites W2330775895 @default.
- W2014924075 cites W2334269816 @default.
- W2014924075 doi "https://doi.org/10.1021/jm5014264" @default.
- W2014924075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25781377" @default.
- W2014924075 hasPublicationYear "2015" @default.
- W2014924075 type Work @default.
- W2014924075 sameAs 2014924075 @default.
- W2014924075 citedByCount "34" @default.
- W2014924075 countsByYear W20149240752016 @default.
- W2014924075 countsByYear W20149240752017 @default.
- W2014924075 countsByYear W20149240752018 @default.
- W2014924075 countsByYear W20149240752019 @default.
- W2014924075 countsByYear W20149240752020 @default.
- W2014924075 countsByYear W20149240752021 @default.
- W2014924075 countsByYear W20149240752022 @default.
- W2014924075 countsByYear W20149240752023 @default.
- W2014924075 crossrefType "journal-article" @default.
- W2014924075 hasAuthorship W2014924075A5000801639 @default.
- W2014924075 hasAuthorship W2014924075A5003120669 @default.
- W2014924075 hasAuthorship W2014924075A5004559759 @default.
- W2014924075 hasAuthorship W2014924075A5013501595 @default.
- W2014924075 hasAuthorship W2014924075A5019503455 @default.
- W2014924075 hasAuthorship W2014924075A5025514242 @default.
- W2014924075 hasAuthorship W2014924075A5027829632 @default.
- W2014924075 hasAuthorship W2014924075A5037772659 @default.
- W2014924075 hasAuthorship W2014924075A5040004308 @default.
- W2014924075 hasAuthorship W2014924075A5044518844 @default.
- W2014924075 hasAuthorship W2014924075A5051132348 @default.